Thermo Fisher Scientific Inc
TMO567.390USD
+11.170+2.01%
Handelsschluss 10/31, 16:00（ET）Kurse um 15 Minuten verzögert
214.25BMarktkapitalisierung
32.61KGV TTM
mehr Informationen über Thermo Fisher Scientific Inc Unternehmen
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
Thermo Fisher Scientific Inc Informationen
BörsenkürzelTMO
Name des UnternehmensThermo Fisher Scientific Inc
IPO-datumAug 27, 1980
CEOMr. Marc N. Casper
Anzahl der mitarbeiter125000
WertpapierartOrdinary Share
GeschäftsjahresendeAug 27
Addresse168 Third Avenue
StadtWALTHAM
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl02451
Telefon17816221000
Websitehttps://www.thermofisher.com/
BörsenkürzelTMO
IPO-datumAug 27, 1980
CEOMr. Marc N. Casper
Führungskräfte von Thermo Fisher Scientific Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.52K
-2.05%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
-3.05%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.47K
-2.38%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
12.74K
-7.01%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
-3.37%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.52K
-2.05%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
-3.05%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.47K
-2.38%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Nach RegionUSD
Name
Umsatz
Anteil
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Aktionärsstatistik
Aktualisiert: Thu, Oct 30
Aktualisiert: Thu, Oct 30
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.90%
BlackRock Institutional Trust Company, N.A.
4.49%
State Street Investment Management (US)
4.36%
Capital World Investors
2.54%
Geode Capital Management, L.L.C.
2.15%
Andere
77.56%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.90%
BlackRock Institutional Trust Company, N.A.
4.49%
State Street Investment Management (US)
4.36%
Capital World Investors
2.54%
Geode Capital Management, L.L.C.
2.15%
Andere
77.56%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.55%
Investment Advisor/Hedge Fund
28.60%
Hedge Fund
3.10%
Bank and Trust
3.00%
Research Firm
2.94%
Pension Fund
2.68%
Sovereign Wealth Fund
1.87%
Family Office
0.21%
Family Office
0.20%
Andere
7.84%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
4325
347.19M
91.94%
-6.74M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Capital Research Global Investors
5.43M
1.44%
-2.18M
-28.62%
Jun 30, 2025
JP Morgan Asset Management
5.38M
1.43%
-1.11M
-17.11%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Mon, Oct 6
Aktualisiert: Mon, Oct 6
Name
Anteil
Monarch Blue Chips Core ETF
4.88%
Honeytree US Equity ETF
4.24%
VanEck Morningstar Wide Moat Value ETF
3.81%
Health Care Select Sector SPDR Fund
3.74%
Proshares Ultra Health Care
3.74%
Goldman Sachs Future Health Care Equity ETF
3.69%
iShares U.S. Healthcare ETF
3.6%
AdvisorShares Focused Equity ETF
3.56%
Parnassus Value Select ETF
3.52%
Invesco Nasdaq Free Cash Flow Achievers ETF
3.39%
Mehr Anzeigen
Monarch Blue Chips Core ETF
Anteil4.88%
Honeytree US Equity ETF
Anteil4.24%
VanEck Morningstar Wide Moat Value ETF
Anteil3.81%
Health Care Select Sector SPDR Fund
Anteil3.74%
Proshares Ultra Health Care
Anteil3.74%
Goldman Sachs Future Health Care Equity ETF
Anteil3.69%
iShares U.S. Healthcare ETF
Anteil3.6%
AdvisorShares Focused Equity ETF
Anteil3.56%
Parnassus Value Select ETF
Anteil3.52%
Invesco Nasdaq Free Cash Flow Achievers ETF
Anteil3.39%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.29B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Feb 22, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 14, 2023
Mar 14, 2023
Nov 10, 2022
TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 16, 2023
Dec 14, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
